The effects of sMEK1 and paclitaxel on carcinoma cells were associated with the induction of apoptosis, as validated by morphological and biochemical analyses, such as DAPI staining, caspase-3 activity, and PARP cleavage. Here, PPP4R3A is linked to carcinoma.